Endoron Medical

Endoron Medical
Develops a novel device for long-lasting sealing and fixation in endovascular aneurysm repair.
About
Technology stack
detected 2026-05-24No comments yet. Be the first to share your take.
What does Endoron Medical do?
Endoron Medical is developing a medical device called Aortoseal, designed to provide a durable sealing and fixation solution for patients undergoing Endovascular Aneurysm Repair (EVAR) for Abdominal Aortic Aneurysm (AAA). The technology aims to replicate the secure and even distribution of sutures used in open surgery, but within a minimally invasive endovascular approach.
How much funding has Endoron Medical raised?
Endoron Medical has raised a total of $10M in funding. The most recent round on record is Series A.
Where is Endoron Medical headquartered?
Endoron Medical is headquartered in Yokneam Illit, Israel.
When was Endoron Medical founded?
Endoron Medical was founded in 2019.
What industry does Endoron Medical operate in?
Endoron Medical operates in Healthcare, Medical Device, MedTech, HealthTech, Cardiovascular, Endovascular Surgery.
How many employees does Endoron Medical have?
Endoron Medical has approximately 16 people on record.
What is Endoron Medical's current status?
Endoron Medical's current operating status is: Inactive.
What is Endoron Medical's revenue?
StartupHub estimates Endoron Medical's annual revenue at $5.2M (range $2.8M to $8.2M, 63% confidence), based on comparable companies in the sector.
What is Endoron Medical's valuation?
StartupHub estimates Endoron Medical's effective valuation at $40.4M (range $25.0M to $60.0M, 15% confidence), based on comparable companies in the sector.
